Stenocare AS STENO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- DKK 2.22
- Day Range
- DKK 2.00–2.22
- 52-Week Range
- DKK 1.81–8.32
- Bid/Ask
- DKK 2.06 / DKK 2.10
- Market Cap
- DKK 41.96 Mil
- Volume/Avg
- 13,564 / 30,131
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 12.40
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Stenocare AS is a Danish company engaged in the cultivation and production of medical cannabis products through pharmacies and hospitals. The Company’s business operations include the distribution and sales of imported products to several markets which also includes local cultivation and production of its medical cannabis products. Stenocare is well positioned to become a market leader in Denmark and a vendor in Europe. The Company is a supplier of medical cannabis oil for patients in Denmerk, Sweden, UK, Australia and Norway. It has an indoor production facility for the cultivation and production of medical cannabis at Randers, Denmark.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 9
- Website
- https://www.stenocare.com
Valuation
|
Metric
|
STENO
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.07 |
Price/Sales | 12.40 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
STENO
|
|---|---|
Quick Ratio | 0.40 |
Current Ratio | 0.68 |
Interest Coverage | −6.00 |
Quick Ratio
STENO
Profitability
|
Metric
|
STENO
|
|---|---|
Return on Assets (Normalized) | −49.64% |
Return on Equity (Normalized) | −70.86% |
Return on Invested Capital (Normalized) | −45.39% |
Return on Assets
STENO
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Fxcnljrcfl | Kclmg | $86.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Ggrcjjljh | Vqwmcl | $74.3 Bil | |||
| Haleon PLC ADR
HLN
| Swryztc | Gvpyc | $45.9 Bil | |||
| Viatris Inc
VTRS
| Dtfqkdz | Mpzh | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Dnfszfzth | Dpct | $13.2 Bil | |||
| Catalent Inc
CTLT
| Bkwhpnrk | Kqykvnn | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Pkrmlyds | Wrxfgz | $3.4 Bil | |||
| Perrigo Co PLC
PRGO
| Mdrknmyp | Sqb | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Bzdptjdtz | Vbfn | $2.4 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Yqpygqth | Dnhzt | $2.2 Bil |
United States